PharmaTher Holdings Ltd. (PHRM.CN)
CAD 0.23
(2.22%)
CAD 0.23
(2.22%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | NaN% |
| Asep Medical Holdings Inc | - CAD | NaN% |
| BetterLife Pharma Inc. | 245.23 Thousand CAD | 100.0% |
| BioVaxys Technology Corp. | - CAD | NaN% |
| ChitogenX Inc. | 3.27 Million CAD | 100.0% |
| Rapid Dose Therapeutics Corp. | 2.12 Million CAD | 100.0% |
| Defence Therapeutics Inc. | 7871.00 CAD | 100.0% |
| Entheon Biomedical Corp. | - CAD | NaN% |
| Gemina Laboratories Ltd. | 205.98 Thousand CAD | 100.0% |
| Glow Lifetech Corp. | - CAD | NaN% |
| Lexston Life Sciences Corp. | - CAD | NaN% |
| Pharmala Biotech Holdings Inc. | - CAD | NaN% |
| Doseology Sciences Inc. | - CAD | NaN% |
| MYND Life Sciences Inc. | - CAD | NaN% |
| Nova Mentis Life Science Corp. | - CAD | NaN% |
| PreveCeutical Medical Inc. | - CAD | NaN% |
| Telescope Innovations Corp. | - CAD | NaN% |